Welterman International Valuation
Is 526431 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 526431 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 526431 (₹16.2) is trading above our estimate of fair value (₹14.51)
Significantly Below Fair Value: 526431 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 526431?
Other financial metrics that can be useful for relative valuation.
What is 526431's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₹71.95m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | 52x |
PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does 526431's PB Ratio compare to its peers?
Company | Forward PB | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.7x | ||
524808 Phyto Chem (India) | 1.8x | n/a | ₹156.5m |
530883 Super Crop Safe | 2.1x | n/a | ₹546.1m |
524534 Bhaskar Agrochemicals | 2.4x | n/a | ₹323.0m |
530433 Shiva Global Agro Industries | 0.4x | n/a | ₹401.9m |
526431 Welterman International | n/a | n/a | ₹71.9m |
Price-To-Book vs Peers: 526431 has negative equity and a Price-To-Book Ratio (-0.6x) compared to the peer average (1.7x).
Price to Earnings Ratio vs Industry
How does 526431's PE Ratio compare vs other companies in the IN Chemicals Industry?
Price-To-Book vs Industry: 526431 has negative equity and a Price-To-Book Ratio (-0.6x) compared to the Indian Chemicals industry average (2.6x).
Price to Book Ratio vs Fair Ratio
What is 526431's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PB Ratio | -0.6x |
Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate 526431's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.